Compare ANDE & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANDE | BCRX |
|---|---|---|
| Founded | 1947 | 1986 |
| Country | United States | United States |
| Employees | N/A | 435 |
| Industry | Farming/Seeds/Milling | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.5B |
| IPO Year | 2005 | 1995 |
| Metric | ANDE | BCRX |
|---|---|---|
| Price | $64.38 | $9.82 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 11 |
| Target Price | ★ $75.00 | $20.82 |
| AVG Volume (30 Days) | 328.8K | ★ 3.2M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.03% | N/A |
| EPS Growth | N/A | ★ 381.40 |
| EPS | ★ 2.62 | N/A |
| Revenue | ★ $11,008,928,000.00 | $25,186,000.00 |
| Revenue This Year | $7.28 | N/A |
| Revenue Next Year | $3.57 | $12.55 |
| P/E Ratio | $24.32 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $37.69 | $6.00 |
| 52 Week High | $82.11 | $11.22 |
| Indicator | ANDE | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 38.02 | 51.75 |
| Support Level | $62.79 | $8.79 |
| Resistance Level | $71.18 | $10.01 |
| Average True Range (ATR) | 2.22 | 0.42 |
| MACD | -0.19 | 0.00 |
| Stochastic Oscillator | 8.14 | 27.54 |
Andersons Inc is an agriculture and renewable fuels company. Its operations are classified into two reportable business segments: Agribusiness, which generates maximum revenue, and Renewables. The Agribusiness segment includes merchandising and managing logistics across various commodities, as well as being a manufacturer, distributor, and retailer of agricultural and related plant nutrients. The segment specializes in the movement of physical commodities such as whole grains, grain products, feed ingredients, and domestic fuel products, among other agricultural commodities. The Renewables segment mainly produces, purchases, and sells ethanol and co-products. Geographically, the company generates maximum revenue from the United States, followed by Canada, Mexico, and other markets.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.